Tag: Novartis

All

Novartis' Cosentyx is the first approved human monoclonal antibody that selectively binds to interleukin IL-17A.

The minimally invasive system uses real-time dual thermal monitoring and cannula-delivered energy to support skin firmness across the face and body.